Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil versus dexmedetomidine for laryngeal mask airway insertion with thiopental induction
ACTRN12625000126415Phase 3Terminated
- Sponsor
- Istanbul Education Research Hospital
- Start
- Dec 2013
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Not applicable comparing Dexmedetomidine + thiopental with Remifentanil + thiopental (2 arms). Primary endpoint: laryngeal mask airway insertion conditions. Started Dec 2013; status: terminated.
02
Drugs
remifentanildexmedetomidinethiopental
03
Conditions
Not applicable
Beyond the preview
Go deeper on ACTRN12625000126415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12625000126415.